Literature DB >> 19857732

Lengthy cold ischemia time is a modifiable risk factor associated with low glomerular filtration rates in expanded criteria donor kidney transplant recipients.

C C Goh1, M Ladouceur, L Peters, C Desmond, J Tchervenkov, D Baran.   

Abstract

The proportion of expanded criteria donor (ECD) kidneys transplanted in North America is steadily increasing. By definition, graft survival is shorter for ECD than standard criteria donor (SCD) kidneys. Seeking to identify factors associated with low posttransplant glomerular filtration rates (GFR), we retrospectively reviewed data on 390 consecutive patients transplanted in our center from January 1999 to December 2006 including 78% SCD and 22% ECD by UNOS criteria. We analyzed donor and patient characteristics, HLA mismatches, cold ischemia time (CIT) and delayed graft function (DGF). Pulsatile perfusion was not used. The average CIT was 14.6 hours for all SCD and ECD cases. All patients received thymoglobulin, a calcineurin inhibitor, mycophenolate mofetil, and steroids. The only factor associated with low estimated GFR in the entire ECD cohort was CIT. The average CIT for the ECD group was 18.3 hours, whereas it was only 13.6 hours for those in the SCD group (P < .001). We observed that at 6 months posttransplant, those in the ECD group are 2.2 times more likely (odds ratio, 2.23; 95% confidence interval, 1.065-4.654; P = .033) to have an estimated GFR < or =50 mL/min/1.73 m(2) compared with those in the SCD group for CIT up to 18 hours. The higher odds ratio for low estimated GFR was sustained at 3 years posttransplant. In our center, a lengthy CIT was an early risk factor associated with impaired renal function. We concluded that all efforts should be made to reduce CIT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857732     DOI: 10.1016/j.transproceed.2009.09.035

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Single centre experience of hypothermic machine perfusion of kidneys from extended criteria deceased heart-beating donors: a comparative study.

Authors:  J C Forde; W P Shields; M Azhar; P J Daly; J A Zimmermann; G P Smyth; M P Eng; R E Power; P Mohan; D P Hickey; D M Little
Journal:  Ir J Med Sci       Date:  2014-12-05       Impact factor: 1.568

2.  Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation.

Authors:  Bendix R Slegtenhorst; Frank Jmf Dor; Hector Rodriguez; Floris J Voskuil; Stefan G Tullius
Journal:  Curr Transplant Rep       Date:  2014-09-01

3.  Predicting Clinical Outcome in Expanded Criteria Donor Kidney Transplantation: A Retrospective Cohort Study.

Authors:  Paramita Saha-Chaudhuri; Carly Rabin; Jean Tchervenkov; Dana Baran; Justin Morein; Ruth Sapir-Pichhadze
Journal:  Can J Kidney Health Dis       Date:  2020-06-24

Review 4.  Tissue conservation for transplantation.

Authors:  Nicco Krezdorn; Sotirios Tasigiorgos; Luccie Wo; Marvee Turk; Rachel Lopdrup; Harriet Kiwanuka; Thet-Su Win; Ericka Bueno; Bohdan Pomahac
Journal:  Innov Surg Sci       Date:  2017-08-08

5.  Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.

Authors:  A Durrbach; J M Pestana; S Florman; M Del Carmen Rial; L Rostaing; D Kuypers; A Matas; T Wekerle; M Polinsky; H U Meier-Kriesche; S Munier; J M Grinyó
Journal:  Am J Transplant       Date:  2016-06-09       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.